FEMPROX®, A TOPICAL ALPROSTADIL CREAM TREATMENT CONVEYS SUSTAINED IMPROVEMENT OF SEXUAL AROUSAL, LUBRICATION AND DESIRE IN WOMEN SUFFERING FROM FEMALE SEXUAL AROUSAL DISORDER (FSAD)

被引：0
|
作者：
Goldstein, I
Damaj, B. [1 ]
Fernando, Y. [1 ]
Frank, D. [1 ]
Moncada, I
机构：
[1] Apricus Biosci, San Diego, CA USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：325 / 325
页数：1
相关论文
共 31 条
  • [31] Comparisons and correlations of 1-month recall vs 24-hour recall in patient-reported outcomes of an exploratory, phase 2b, randomized, double-blind, placebo-controlled clinical trial of sildenafil cream, 3.6% for the treatment of female sexual arousal disorder
    Johnson, Isabella
    Thurman, Andrea Ries
    Cornell, Katherine A.
    Symonds, Tara
    Hatheway, Jessica
    Friend, David R.
    Goldstein, Andrew
    JOURNAL OF SEXUAL MEDICINE, 2024, 21 (09): : 787 - 792
1234